Charity Alliance To Sink £30m Into Brain Disease Research
A new global coalition* of nine charities and funding bodies will oversee the investment of up to £30 million into kickstarting the development of promising drug candidates for neurodegenerative conditions such as dementia, motor neurone disease and Parkinson’s disease.
The Neurodegeneration Medicines Acceleration Programme (Neuro-MAP), led by medical research charity MRC Technology, aims to seek out promising drug projects for which industry has stalled development, bring them up to the next level, and then hand them back to pharmaceutical companies for further development.
Help employers find you! Check out all the jobs and post your resume.
The Neurodegeneration Medicines Acceleration Programme (Neuro-MAP), led by medical research charity MRC Technology, aims to seek out promising drug projects for which industry has stalled development, bring them up to the next level, and then hand them back to pharmaceutical companies for further development.
Help employers find you! Check out all the jobs and post your resume.